Windtree Therapeutics, Inc. (WINT) Stock price, Description, News & Info

#ThinkSabio Latest News

Windtree Receives Non-Binding Letter Of Intent To Purchase Its Preclinical Oncology Drug Candidate For $7M Up Front And Up To $130M In Milestones With Up To $1.5B In Royalties

Light
Dark